Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme (Q28205919)
Jump to navigation
Jump to search
scientific article (publication date: May 2002)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme |
scientific article (publication date: May 2002) |
Statements
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme (English)
0 references
May 2002
0 references
13
0 references
5
0 references
777-80
0 references